Healthcare provider profile · identity verified

Elena O Mccabe

Family Practice · WOMELSDORF, PA · NPI 1760617294

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	792	233
Amlodipine Besylate	Amlodipine Besylate	664	190
Levothyroxine Sodium	Levothyroxine Sodium	540	150
Simvastatin	Simvastatin	434	113
Metoprolol Succinate	Metoprolol Succinate	406	122
Lisinopril	Lisinopril	339	98
Losartan Potassium	Losartan Potassium	338	102
Omeprazole	Omeprazole	327	108
Furosemide	Furosemide	257	99
Metformin Hcl	Metformin Hcl	256	76
Gabapentin	Gabapentin	235	69
Pantoprazole Sodium	Pantoprazole Sodium	227	72
Metoprolol Tartrate	Metoprolol Tartrate	225	67
Atenolol	Atenolol	219	62
Pravastatin Sodium	Pravastatin Sodium	217	63
Famotidine	Famotidine	211	81
Hydrochlorothiazide	Hydrochlorothiazide	196	64
Sertraline Hcl	Sertraline Hcl	181	55
Allopurinol	Allopurinol	179	52
Rosuvastatin Calcium	Rosuvastatin Calcium	174	54
Alprazolam	Alprazolam	164	57
Fluticasone Propionate	Fluticasone Propionate	163	72
Valsartan	Valsartan	157	42
Tamsulosin Hcl	Tamsulosin Hcl	148	45
Ezetimibe	Ezetimibe	138	41
Tramadol Hcl	Tramadol Hcl	127	30
Trazodone Hcl	Trazodone Hcl	119	38
Potassium Chloride	Potassium Chloride	117	38
Glipizide Er	Glipizide	115	35
Montelukast Sodium	Montelukast Sodium	113	33
Metformin Hcl Er	Metformin Hcl	112	36
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	111	30
Mirtazapine	Mirtazapine	108	46
Lorazepam	Lorazepam	107	32
Prednisone	Prednisone	107	85
Pioglitazone Hcl	Pioglitazone Hcl	103	33
Albuterol Sulfate Hfa	Albuterol Sulfate	99	52
Eliquis	Apixaban	98	30
Synthroid	Levothyroxine Sodium	98	29
Spironolactone	Spironolactone	97	30
Duloxetine Hcl	Duloxetine Hcl	94	27
Meloxicam	Meloxicam	85	37
Xarelto	Rivaroxaban	83	19
Clopidogrel	Clopidogrel Bisulfate	82	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	77	26
Cephalexin	Cephalexin	76	68
Fosinopril Sodium	Fosinopril Sodium	75	19
Hydralazine Hcl	Hydralazine Hcl	74	25
Tizanidine Hcl	Tizanidine Hcl	73	23
Breo Ellipta	Fluticasone/Vilanterol	71	18
Citalopram Hbr	Citalopram Hydrobromide	68	23
Doxycycline Monohydrate	Doxycycline Monohydrate	67	62
Klor-Con M10	Potassium Chloride	67	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	67	21
Alendronate Sodium	Alendronate Sodium	66	22
Jardiance	Empagliflozin	64	16
Propranolol Hcl	Propranolol Hcl	64	18
Zolpidem Tartrate	Zolpidem Tartrate	63	22
Azithromycin	Azithromycin	62	54
Januvia	Sitagliptin Phosphate	61	15
Donepezil Hcl	Donepezil Hcl	60	18
Carvedilol	Carvedilol	57	18
Glimepiride	Glimepiride	55	16
Paroxetine Hcl	Paroxetine Hcl	55	16
Esomeprazole Magnesium	Esomeprazole Magnesium	52	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	50	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	48	41
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	47	21
Ozempic	Semaglutide	47	13
Amoxicillin	Amoxicillin	46	43
Diclofenac Sodium	Diclofenac Sodium	45	14
Ramipril	Ramipril	45	12
Nateglinide	Nateglinide	44	12
Buspirone Hcl	Buspirone Hcl	43	12
Oxycodone Hcl	Oxycodone Hcl	43	14
Fluoxetine Hcl	Fluoxetine Hcl	42	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	41	13
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	40	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	40	11
Klor-Con M20	Potassium Chloride	40	14
Celecoxib	Celecoxib	39	suppressed
Glipizide	Glipizide	38	12
Trulicity	Dulaglutide	37	suppressed
Azelastine Hcl	Azelastine Hcl	36	14
Bupropion Xl	Bupropion Hcl	36	12
Lovastatin	Lovastatin	35	suppressed
Finasteride	Finasteride	34	14
Amitriptyline Hcl	Amitriptyline Hcl	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	33	11
Fenofibrate	Fenofibrate	32	suppressed
Verapamil Er	Verapamil Hcl	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	31	27
Clonazepam	Clonazepam	30	suppressed
Nifedipine Er	Nifedipine	29	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Nystatin	Nystatin	27	18
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	21
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	16
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Fluconazole	Fluconazole	25	17
Nitroglycerin	Nitroglycerin	25	15
Mounjaro	Tirzepatide	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	15
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Topiramate	Topiramate	24	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	23	18
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	22	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	20	18
Tradjenta	Linagliptin	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	19	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Mupirocin	Mupirocin	18	16
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Ammonium Lactate	Ammonium Lactate	17	15
Ampicillin Trihydrate	Ampicillin Trihydrate	17	15
Benazepril Hcl	Benazepril Hcl	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Methylprednisolone	Methylprednisolone	17	17
Midodrine Hcl	Midodrine Hcl	17	suppressed
Mometasone Furoate	Mometasone Furoate	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Lidocaine	Lidocaine	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Cefdinir	Cefdinir	15	15
Isosorbide Dinitrate	Isosorbide Dinitrate	15	suppressed
Levofloxacin	Levofloxacin	15	14
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Warfarin Sodium	Warfarin Sodium	15	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Naproxen	Naproxen	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Metronidazole	Metronidazole	13	13
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Bupropion Hcl	Bupropion Hcl	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Mesalamine Er	Mesalamine	12	suppressed
Atovaquone	Atovaquone	11	suppressed
Estradiol	Estradiol	11	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error